Pfizer Abrocitinib to treat atopic dermatitis meet goals in late-stage study Garima18 May 2019 9:30 AM ISTAbrocitinib, which belongs to a class of drugs known as JAK inhibitors, which block inflammation-causing enzymes, known as Janus kinases, achieved...
Roche gets USFDA nod for combo drug Venclexta, Gazyva to treat lymphocytic leukaemia Medical Dialogues Bureau17 May 2019 9:15 AM IST"Venclexta plus Gazyva is the only chemotherapy-free option of fixed duration that provides durable responses to help people live longer without...
Eli Lilly gets USFDA nod for Cyramza to treat hepatocellular carcinoma Medical Dialogues Bureau14 May 2019 9:47 AM ISTThe USFDA has removed the boxed warning from the CYRAMZA labelling which highlighted warnings pertaining to haemorrhage, gastrointestinal perforation...
Pfizer acquires clinical-stage Biotech Therachon for $810 million Garima12 May 2019 9:45 AM ISTNEW YORK: Pfizer recently announced that it has entered into a definitive agreement to acquire all the shares of Therachon Holding AG, a privately...
Eli Lilly new migraine drug Emgality pulls ahead of Amgen in battle for prescriptions Farhat Nasim12 May 2019 9:30 AM ISTWeekly U.S. prescription data from IQVIA, an analytics provider to the life sciences industry, showed that Lilly's therapy Emgality claimed the...
Following opioid suits, family behind deadly OxyContin squabbles Medical Dialogues Bureau11 May 2019 9:00 AM ISTNEW YORK: A united front among members of the billionaire Sackler family behind painkiller OxyContin is showing signs of strain from litigation over...
Unichem Labs gets tentative USFDA nod for generic version of JnJ Zyrtec-D 12 Hour Farhat Nasim9 May 2019 10:15 AM ISTUnichem Lab's approved drug is a generic copy of Zyrtec-D 12 Hour which is used for treating allergic rhinitis.New Delhi: Unichem Laboratories Tuesday...
Pfizer gets USFDA nod for potential blockbuster heart drug Tafamidis Medical Dialogues Bureau7 May 2019 9:45 AM ISTPfizer, which has touted tafamidis as a potential blockbuster product, set a list price of $225,000 a year for the medicine, which would be sold under...
AbbVie wins USFDA nod for Mavyret to treat HCV genotypes in pediatric patients Farhat Nasim3 May 2019 9:10 AM ISTNew Delhi: AbbVie Inc. recently won the U.S. Food and Drug Administration (USFDA) approval for Mavyret (glecaprevir and pibrentasvir) tablets to treat...
USFDA declines to approve Nabriva's antibiotic Contepo for urinary tract infections Medical Dialogues Bureau1 May 2019 12:02 PM ISTThe U.S. Food and Drug Administration on Tuesday declined to approve Nabriva Therapeutics Plc's antibiotic Contepo for complicated urinary tract...
Using AI to detect mental health disorders likely to be counterproductive Medical Dialogues Bureau30 April 2019 9:00 AM ISTAI-based vocal analytics may allow patients to detect the disease at home by just speaking into a smartphone application, eliminating the need to be...
Pfizer gets CHMP opinion for Talzenna for patients with metastatic breast cancer Farhat Nasim29 April 2019 9:35 AM ISTThe positive CHMP opinion of TALZENNA follows the medicine's approval by the U.S. Food and Drug Administration (FDA) in October 2018.New Delhi:...
